Clinical Trial Update: Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sevoflurane effects on extravascular lung water and pulmonary vascular permeability in patients with ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: Bicetre Hospital | Conditions: ARDS, ARDS, Human | Phase 3 | Status: UNKNOWN